A randomized controlled trial evaluating outcome impact of cilostazol in patients with coronary artery disease and at a high risk of cardiovascular disease
1 September 2019 (12:40 - 13:30)
Organised by:
Abstract
About the speaker

Chung Shan Medical University Hospital, Taichung (Taiwan)
6 More presentations in this session
Doctor R. Boudreau (Ottawa, CA)
Access the full session
The Event
ESC Congress 2019
1 September 2019
12:40 CET


